StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) stock

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 14/3034% above fair value
$104.71−2.74 (-2.55%)

Close on Nov 17, 2026Market cap $181.19BP/E 33.7Yield 2.29%

Abbott Laboratories price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Abbott Laboratories's price to sales ratio was 4.1× on Nov 11, 2026, against 5.1× a year earlier. Over the last 5 years it ranged from 3.3× to 6.0×, with a median of 4.6×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20264.1×−0.9
2025Dec 31, 20255.0×+0.2
2024Dec 31, 20244.8×−0.0
2023Dec 29, 20234.8×+0.5
2022Dec 30, 20224.3×−1.6
2021Dec 31, 20216.0×−0.1
2020Dec 31, 20206.1×+1.1
2019Dec 31, 20194.9×+0.7
2018Dec 31, 20184.2×+0.4
2017Dec 29, 20173.8×+1.1
2016Dec 30, 20162.8×−0.5
2015Dec 31, 20153.3×−0.2
2014Dec 31, 20143.5×+0.5
2013Dec 31, 20133.0×−1.0
2012Dec 31, 20124.0×+1.7
2011Dec 30, 20112.3×+0.1
2010Dec 31, 20102.2×−0.6
2009Dec 31, 20092.8×–

More Abbott Laboratories figures

See a number that looks wrong?